Tamir Tal, CEO, Cordio Medical, explains how AI voice biomarker technology and the advancement of a diagnostic app from a smartphone can transform diagnosis of early diseases.
Read more here.
Tamir Tal, CEO, Cordio Medical, explains how AI voice biomarker technology and the advancement of a diagnostic app from a smartphone can transform diagnosis of early diseases.